31 research outputs found
Recommended from our members
Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management
Get PDFAs of April 21, 2020, more than 2.5 million cases of coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, have been reported in 210 countries and territories, with the death toll at 171,810. Both chloroquine and hydroxychloroquine have gained considerable media attention as possible therapies, resulting in a significant surge in demand. In overdose, both medications can cause severe, potentially life-threatening effects. Here, we present a brief overview of the pharmacology of chloroquine and hydroxychloroquine, manifestations of toxicity, and treatment considerations
Return Encounters in Emergency Department Patients Treated with Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal
No full textEmerging Drugs of Abuse: Synthetic Cannabinoids, Phenylethylamines (2C Drugs), and Synthetic Cathinones
Full text linkResponse to: "Management of Chloroquine and Hydroxychloroquine Poisoning: Do Not Miss the Time of Tracheal Intubation and Mechanical Ventilation"
No full textResponse to “The Mechanisms Underlying Methylene Blue-Mediated Attenuation of Nitric Oxide-induced Vasodilatation”
Full text linkComment on Fomepizole as an adjunct in acetylcysteine treated acetaminophen overdose patients: a case series
Full text linkRecommended from our members
Response to: "Management of Chloroquine and Hydroxychloroquine Poisoning: Do Not Miss the Time of Tracheal Intubation and Mechanical Ventilation"
No full text
